Gates’ Globalist Vaccine Agenda: A Win-Win for Pharma and

New Post Public Reply Private Reply Replies (2) Message Board
wowhappens28 energy_wave #43420
210
Gates’ Globalist Vaccine Agenda: A Win-Win for Pharma and Mandatory Vaccination

https://childrenshealthdefense.org/news/gover...ccination/

Vaccines, for Bill Gates, are a strategic philanthropy that feed his many vaccine-related businesses (including Microsoft’s ambition to control a global vaccination ID enterprise) and give him dictatorial control of global health policy.

Gates’ obsession with vaccines seems to be fueled by a conviction to save the world with technology.

Promising his share of $450 million of $1.2 billion to eradicate Polio, Gates took control of India’s National Technical Advisory Group on Immunization (NTAGI) which mandated up to 50 doses (Table 1) of polio vaccines through overlapping immunization programs to children before the age of five. Indian doctors blame the Gates campaign for a devastating non-polio acute flaccid paralysis (NPAFP) epidemic that paralyzed 490,000 children beyond expected rates between 2000 and 2017. In 2017, the Indian government dialed back Gates’ vaccine regimen and asked Gates and his vaccine policies to leave India. NPAFP rates dropped precipitously.

In 2017, the World Health Organization (WHO) reluctantly admitted that the global explosion in polio is predominantly vaccine strain. The most frightening epidemics in Congo, Afghanistan, and the Philippines, are all linked to vaccines. In fact, by 2018, 70% of global polio cases were vaccine strain.

In 2014, the Gates Foundation funded tests of experimental HPV vaccines, developed by Glaxo Smith Kline (GSK) and Merck, on 23,000 young girls in remote Indian provinces. Approximately 1,200 suffered severe side effects, including autoimmune and fertility disorders. Seven died. Indian government investigations charged that Gates-funded researchers committed pervasive ethical violations: pressuring vulnerable village girls into the trial, bullying parents, forging consent forms, and refusing medical care to the injured girls. The case is now in the country’s Supreme Court.

In 2010, the Gates Foundation funded a phase 3 trial of GSK’s experimental malaria vaccine, killing 151 African infants and causing serious adverse effects including paralysis, seizure, and febrile convulsions to 1,048 of the 5,949 children.

During Gates’ 2002 MenAfriVac campaign in Sub-Saharan Africa, Gates’ operatives forcibly vaccinated thousands of African children against meningitis. Approximately 50 of the 500 children vaccinated developed paralysis. South African newspapers complained, “We are guinea pigs for the drug makers.” Nelson Mandela’s former Senior Economist, Professor Patrick Bond, describes Gates’ philanthropic practices as “ruthless and immoral.”

In 2010, Gates committed $10 billion to the WHO saying, “We must make this the decade of vaccines.” A month later, Gates said in a Ted Talk that new vaccines “could reduce population”. In 2014, Kenya’s Catholic Doctors Association accused the WHO of chemically sterilizing millions of unwilling Kenyan women with a “tetanus” vaccine campaign. Independent labs found a sterility formula in every vaccine tested. After denying the charges, WHO finally admitted it had been developing the sterility vaccines for over a decade. Similar accusations came from Tanzania, Nicaragua, Mexico, and the Philippines.

A 2017 study (Morgenson et. al. 2017) showed that WHO’s popular DTP vaccine is killing more African children than the diseases it prevents. DTP-vaccinated girls suffered 10x the death rate of children who had not yet received the vaccine. WHO has refused to recall the lethal vaccine which it forces upon tens of millions of African children annually.

Global public health advocates around the world accuse Gates of steering WHO’s agenda away from the projects that are proven to curb infectious diseases: clean water, hygiene, nutrition, and economic development. The Gates Foundation only spends about $650 million of its $5 billion dollar budget on these areas. They say he has diverted agency resources to serve his personal philosophy that good health only comes in a syringe.

In addition to using his philanthropy to control WHO, UNICEF, GAVI, and PATH, Gates funds a private pharmaceutical company that manufactures vaccines, and additionally is donating $50 million to 12 pharmaceutical companies to speed up development of a coronavirus vaccine. In his recent media appearances, Gates appears confident that the Covid-19 crisis will now give him the opportunity to force his dictatorial vaccine programs on American children.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cooper's Stock Takes a Beating: What's Behind It?

Updated Category News Views 45

A Shock to the System: Cooper's Rough Patch Not every day you see a stock take a body slam like this! Cooper Companies (NASDAQ: COO) got walloped after revealing some unsavory truths about its Q3 2026 performance. The market didn't just flinch—it reeled. On September 10, 2026, COO shares dove a steep $9.31—around a 14.6% free fall—whacking off over $1.7 billion in...

Continue Reading
Blue Moon Metals Scraps Major Acquisition Plan

Updated Category News Views 87

Blue Moon Metals' Acquisition Detour Blue Moon Metals Inc. (NASDAQ: BMM), a name that's been stirring up chatter for its ambitious mining ventures, has waved goodbye to its planned acquisition of 33 U.S.-based tungsten and antimony projects. This move, announced on October 30, 2026, may have caught some investors off guard. The acquisition sounded like a good fit: a...

Continue Reading
Lecanemab's New Data: What Investors Should Monitor

Updated Category News Views 71

Lecanemab: A Bold Step in Alzheimer's Treatment? Investors eyeing the biotech sector should pay close attention to the upcoming CTAD conference in 2026, where BioArctic AB's partner, Eisai, is set to present fresh data on lecanemab (Leqembi®). This isn't just another pharma front-page story—this is about potential breakthroughs in Alzheimer's treatment that's caught...

Continue Reading
Tetragon's September Factsheet Offers Unique Insights

Updated Category News Views 115

A Peek into Tetragon's Financial Playbook Every once in a while, you come across a player in the finance world that operates by its own rules. Tetragon Financial Group is one of those mavericks, and they've dropped their September 2026 Monthly Factsheet. Now here's a company that knows how to keep you guessing while serving up some real financial meat. Investment Strategy...

Continue Reading
Ping Identity Tops 2026 Gartner Magic Quadrant: CIAM

Updated Category News Views 20

Turning Heads in the Cybersecurity Space When it comes to digital security, Ping Identity has snagged a top spot in Gartner's 2026 Magic Quadrant for Customer Identity and Access Management (CIAM). Some might gloss over these annual reports like yesterday's news, but Ping isn't just playing around here. They've been tapped as a Leader again, and this accolade highlights...

Continue Reading
OneMain Holdings' Q3 2026: Mixed Signals in Nonprime Sector

Updated Category News Views 72

Third Quarter Earnings: A Double-Edged Sword OneMain Holdings, Inc. (NYSE: OMF) rolled its Q3 2026 numbers out, and they look like a classic cocktail of high hopes and looming risks. On the surface, a diluted EPS of $1.60 might not sound like a knockout punch to the jaw, but let’s not forget they’ve taken a step back from last year’s $1.67. Their net income of $185...

Continue Reading
Kanazawa's Winter Crab Course Brings Flavor to Life

Updated Category News Views 60

An Unexpected Dance of Flavors Nestled in Kanazawa’s Nishi Chaya District, Canisienne Kanazawa isn’t just another eatery—it’s an engulfing dive into the world of winter crab extravagance. Picture yourself at an intimate, eight-seat counter, where chefs transform live crabs into culinary masterpieces right before your eyes. From early November to the end of...

Continue Reading
OCI Cleared to Merge with Orascom, Sets Delisting Date

Updated Category News Views 131

OCI N.V. has hit a milestone. The shareholders have given the green light to merge with Orascom Construction PLC. This move is fleshed out with an updated roadmap that sharp-eyed investors need to watch closely. The company's shares will no longer be trading on Euronext Amsterdam by late November 2026, contingent on regulatory nods and other variables swirling in the...

Continue Reading
Senior Living Amenities: Beyond the Initial Tour Expectations

Updated Category News Views 66

Untangling the Frontloaded Focus on Senior Living When folks first wade into the sea of senior living options, they tend to hitch their wagons to the more obvious aspects like apartment size and healthcare services. But man, do we all sometimes get lost in the forest for the trees. What swerves the experience most in the senior community sphere are those amenities folks...

Continue Reading
Trade Cases on Pizza Box Imports Set Industry Ablaze

Updated Category News Views 66

U.S. Takes Stand Against Unfair Import Practices Who knew pizza boxes could stir up such a fuss, huh? Well, here we are. The U.S. International Trade Commission (ITC) has sided with American pizza box manufacturers, waving the flag against those sneaky imports from China, Malaysia, and Turkey. According to the ITC, these imports are causing some real headaches for the...

Continue Reading

Top 5 Most Recently Viewed Articles

CubeSmart Shares Positive Q3 Results and Future Strategies

Updated Category News Views 111

CubeSmart Announces Impressive Third Quarter Results MALVERN, Pa. — CubeSmart (NYSE: CUBE) has shared its operating outcomes for the three and nine months ending September 30, showcasing a robust performance in a competitive self-storage market. "This quarter underscores our commitment to maintaining stability amid challenges in customer rental rates. We are also proud...

Continue Reading
El Pollo Loco Launches Spicy Mango Habanero Sauce Test

Updated Category News Views 445

El Pollo Loco Introduces a New Flavor Sensation El Pollo Loco, well-loved as a leading fire-grilled chicken restaurant, is stirring excitement with its latest culinary creation—the Mango Habanero sauce. This thrilling test run, situated in select locations, is aimed at providing an extraordinary taste experience for diners. Who Is Behind This Spicy Adventure? El Pollo...

Continue Reading
Agnico Eagle Expands Its Stake in Foran Mining Corporation

Updated Category News Views 448

Agnico Eagle Makes Strategic Investment in Foran Mining Stock Symbol: AEM (NYSE and TSX) Agnico Eagle Mines Limited (NYSE: AEM) has announced an agreement to subscribe to 30,000,000 voting common shares of Foran Mining Corporation in a private placement valued at C$90,000,000. This investment is structured to close in two tranches, subject to regulatory approvals and...

Continue Reading
Aris Mining Unveils Strong PEA Outcomes for Toroparu Project

Updated Category News Views 297

Positive PEA Outcomes for Toroparu Gold Project The PEA highlights a long-life, low-cost open pit gold operation with a 25.2% IRR. In Vancouver, Aris Mining Corporation (Aris Mining) recently released the positive results from their preliminary economic assessment (PEA) of the 100%-owned Toroparu Gold Project. This assessment confirms that Toroparu represents a...

Continue Reading
Transforming Healthcare: Insights from the Global Health Exhibition

Updated Category News Views 157

Exciting Preparations for the Global Health Exhibition The Kingdom of Saudi Arabia is preparing to host the Global Health Exhibition, a major international event anticipated to draw over 100,000 participants. This year, the exhibition will be held in Malham, featuring a venue that is double the size of previous years, with more than 1,200 exhibiting companies and brands...

Continue Reading